Skip to main content
CNTX
NASDAQ Life Sciences

Partial Response Reported for Context's CTIM-76, Key Milestones Ahead; Cash Runway into Mid-2027

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$3.02
Mkt Cap
$277.475M
52W Low
$0.49
52W High
$3.62
52W Position info
516% above low
Off High info
17% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

CNTX has more than doubled off its 52-week low of $0.49 on light trading volume (0.3× avg).

Summary

Context Therapeutics has updated its corporate presentation, revealing a reported partial response in its ongoing Phase 1a trial for CTIM-76. This positive clinical signal is significant for the company's lead oncology candidate. The update also flags upcoming interim Phase 1a data for CTIM-76 in June 2026 and for CT-95 in September 2026, alongside the expected first patient in Phase 1 for CT-202 in Q3 2026. Crucially, the company confirmed a cash runway extending into mid-2027, providing financial stability to advance its pipeline. These clinical developments and financial clarity are material for a small-cap biotech, offering multiple potential catalysts throughout 2026 and 2027.

At the time of this announcement, CNTX was trading at $3.02 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $277.5M. The 52-week trading range was $0.49 to $3.62. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

CNTX - Latest Insights

CNTX
Nov 10, 2026, 4:16 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.1875
Real-time Price: $0.1575 info
Change: -$0.030 (-16%) info
Market Cap: $14.627M info
CNTX
Nov 10, 2026, 4:12 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.1875
Real-time Price: $0.1575 info
Change: -$0.030 (-16%) info
Market Cap: $14.627M info
CNTX
Aug 06, 2026, 1:32 AM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $0.482
Real-time Price: $0.1575 info
Change: -$0.3245 (-67%) info
Market Cap: $14.627M info
CNTX
Aug 05, 2026, 4:58 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.660
Real-time Price: $0.1575 info
Change: -$0.5025 (-76%) info
Market Cap: $14.627M info
CNTX
Jul 31, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.5994
Real-time Price: $0.1575 info
Change: -$0.4419 (-74%) info
Market Cap: $14.627M info